EXPLAINER

Forgetting names and misplacing keys: when is memory slippage normal and when is it not?

Everyday lapses are a poor guide to trouble. The line that matters is whether memory loss is measurable beyond your age and whether it is starting to affect daily function.

Prevalence of mild cognitive impairment by age band (AAN guideline)60-64: 6.7%; 65-69: 8.4%; 70-74: 10.1%; 75-79: 14.8%; 80-84: 25.2%0%15%30%60-646.7%65-698.4%70-7410.1%75-7914.8%80-8425.2%
Prevalence of mild cognitive impairment by age band (AAN guideline)
GroupValue (%)
60-646.7
65-698.4
70-7410.1
75-7914.8
80-8425.2
Prevalence of mild cognitive impairment by age band (AAN guideline) Cross-sectional prevalence estimates from the American Academy of Neurology's systematic review. Prevalence rises steeply with age but most people in every band do not have MCI. Source: Neurology (American Academy of Neurology)

Walking into a room and forgetting why, blanking on a familiar name, misplacing keys, losing a word for a moment — these are the lapses that send people to search engines at 2am convinced they are watching early dementia. Most of the time they are not. The features that actually distinguish normal ageing from something worth investigating are more specific, and they are not the ones people tend to fixate on.

Normal ageing genuinely slows some things down

Some decline in memory and mental speed is a normal part of getting older. Retrieval gets slower — the name that surfaces a minute later, the multitasking that feels harder than it did at 30. What tends to stay intact in normal ageing is the ability to function: you eventually find the word, you still manage your finances, medications, appointments and relationships without new help. Occasional lapses that do not accumulate or interfere with daily life are the background hum of an older brain, not a disease.

The more informative signals run the other way. Memory loss that is getting steadily worse, that others notice more than you do, that involves forgetting whole recent events rather than isolated details, or that starts to erode everyday competence — missed bills, repeated questions, getting lost on familiar routes — is the pattern that warrants a proper assessment. The direction and the functional impact matter more than any single embarrassing blank.

What "mild cognitive impairment" actually means

Between normal ageing and dementia sits a defined clinical stage: mild cognitive impairment, or MCI. It describes cognitive decline that is measurable — greater than expected for a person's age and education on testing — but not yet severe enough to compromise independent daily function. That last clause is the dividing line from dementia, where function is impaired.

MCI is common and becomes more so with age. The American Academy of Neurology's guideline review put its prevalence at 6.7% for ages 60 to 64, 8.4% for 65 to 69, 10.1% for 70 to 74, 14.8% for 75 to 79, and 25.2% for 80 to 84 [s1]. So even among people in their early 80s, roughly three in four do not meet criteria for MCI. It is a real category, not a euphemism for early dementia — and crucially, an MCI diagnosis is not a sentence. In people over 65 with MCI followed for two years, the cumulative incidence of progression to dementia was 14.9% [s1]. Many others remained stable, and some reverted toward normal.

When the worry itself is the symptom

There is a further, subtler category. Some people experience a persistent sense that their memory is slipping while still performing normally on cognitive tests — a state researchers call subjective cognitive decline [s2]. On average it carries a modestly raised risk of future decline, but it is highly heterogeneous: for many people it reflects stress, low mood, poor sleep or medication rather than any neurodegenerative process, and the majority do not go on to develop dementia [s2]. The bare fact of being worried about your memory is not, by itself, diagnostic of anything.

What to do with all this

Two practical rules follow. First, watch the trajectory and the function, not the individual lapse. A stable pattern of ordinary forgetfulness that does not interfere with life is reassuring; a clear decline over months, especially one that is affecting daily tasks or that family members are flagging, is worth raising with a clinician who can test formally and look for reversible contributors — thyroid problems, vitamin deficiencies, depression, sleep disorders and cognitively impairing medications among them.

Second, the response to an MCI diagnosis is not despair. The guideline found no high-quality evidence supporting any drug for MCI, but did find that six months of exercise training is likely to improve cognitive measures, and that cognitive training may help [s1]. Those overlap with the modifiable risk factors — activity, vascular health, engagement — that the Lancet Commission links to lower dementia risk across the population [s3]. None of it guarantees an outcome. But it means the honest message for someone noticing everyday slips is closer to "here is what the line actually is, and here is what helps" than to the catastrophe the search results imply.

This article is informational and is not medical advice.

Sources

  1. Practice guideline update summary: Mild cognitive impairment — Neurology (American Academy of Neurology) , December 27, 2017
  2. The characterisation of subjective cognitive decline — The Lancet Neurology , March 1, 2020
  3. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission — The Lancet , July 31, 2024

More on

Related coverage